shield-check-line
Third-Party Testing Results

Every batch is independently tested by Janoshik for quality and transparency.

Powered by TESTIDES
VERIFIED
This batch has passed all tests.

High purity and accurate concentration.

shield-check-line
Purity

High Purity

Identity
Confirmed
Concentration

Accurate

Compounds

No Harmful Additives

Arimidex

Quantity
Total
$80.00
$25 standard shipping across CanadaFree shipping on orders over $499

Product Information

Arimidex is the brand name for anastrozole, an oral non-steroidal aromatase inhibitor. It reduces estrogen production by inhibiting the enzyme responsible for converting androgens into estrogens. Anastrozole is a prescription medication primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women.

Active Compound
Arimidex
Concentration
1mg
Volume
50 count
Packaging
Sachet
Intended Use
Oral
Storage
Store at 15–30°C. Protect from light.
Manufacturer
Biogenix Pharma
Active-Life
4-6 Hours

Product Overview

Arimidex (anastrozole) is a prescription aromatase inhibitor used primarily to treat hormone receptor-positive breast cancer in postmenopausal women.

Some breast cancers rely on estrogen to grow. Anastrozole reduces estrogen production by inhibiting aromatase, an enzyme involved in converting androgens into estrogen. This can help slow or stop the growth of estrogen-sensitive cancer cells.

Treatment may be prescribed as adjuvant therapy following surgery, for advanced breast cancer, or in other clinically appropriate settings. The specific treatment plan depends on the cancer’s characteristics, stage, and the patient’s medical history.

Clinical Considerations

Anastrozole is not a general-purpose estrogen-management solution. Its effects depend on the individual’s hormonal status, medical condition, and other medications.

In men, inappropriate estrogen suppression may negatively affect bone health, libido, sexual function, and overall well-being. Claims that anastrozole reliably prevents all estrogen-related effects associated with anabolic steroid use are not supported.

Use should be guided by a qualified healthcare professional and appropriate clinical assessment.